secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2025-07-23T23:59:59+00:00
Accession:  0001193125-25-163400
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rein Therapeutics stockholders elect director Fairey, approve say-on-pay
------------------------------------------------------------------------

- William C. Fairey elected as Class II director for three-year term expiring 2028; 7,661,847 for, 1,621,599 withheld.
- Advisory vote on named executive officer compensation approved: 8,325,803 for, 146,938 against, 810,705 abstain.
- Meeting held July 23, 2025, after being adjourned from June 24, 2025; no broker non-votes recorded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525163400/0001193125-25-163400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312525163400/d931384d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-163400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer